
### [NCIT:C96510](http://purl.obolibrary.org/obo/NCIT_C96510)
**Label:** Colorectal Kaposi Sarcoma

**Subclasses:** [NCIT:C5516](http://purl.obolibrary.org/obo/NCIT_C5516) (Colon Kaposi Sarcoma), [NCIT:C5550](http://purl.obolibrary.org/obo/NCIT_C5550) (Rectal Kaposi Sarcoma), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C53413](http://purl.obolibrary.org/obo/NCIT_C53413) (Malignant Oval Endothelial Cell) 51.67%
- [NCIT:C53405](http://purl.obolibrary.org/obo/NCIT_C53405) (Malignant Spindle Endothelial Cell) 51.67%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) 51.67%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 48.30%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 48.30%


